Inhibitors of Serine Proteases, Particularly Hepatitis C Virus NS3 Protease

Details for Australian Patent Application No. 2006202124 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors O'Malley, Ethan; Bhisetti, Govinda Rao; Perni, Robert; Court, John

Agent Cullens

Pub. Number AU-B-2006202124

Parent 2001251165

Filing date 19 May 2006

Wipo publication date 8 June 2006

Acceptance publication date 21 January 2010

International Classifications

C07D 203/00 (2006.01) Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 205/00 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

C07K 5/103 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

8 June 2006 Application Open to Public Inspection

  Published as AU-B-2006202124

8 June 2006 Complete Application Filed

21 January 2010 Application Accepted

  Published as AU-B-2006202124

20 May 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006202125-An Advertising System Using Cups

2006202123-A game